Verano Holdings (VRNO) FCF Payout Ratio (2025)
Verano Holdings' (VRNO) quarterly FCF Payout Ratio came in at 0.39 in Q1 2025.
Verano Holdings (VRNO) FCF Payout Ratio (2025) Analysis & Trends
Verano Holdings (VRNO) has 1 years of FCF Payout Ratio data on file, last reported at 0.39 in Q1 2025.
- On a quarterly basis, FCF Payout Ratio changed N/A year-over-year to 0.39 in Q1 2025; TTM through Dec 2025 was 0.4, a N/A change from a year earlier, with the FY2025 full-year figure at 0.4, changed N/A from the prior year.
- FCF Payout Ratio for Q1 2025 stood at 0.39.
- Over the last five years, FCF Payout Ratio for VRNO reached as high as 0.39 in Q1 2025 and fell as low as 0.39 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.77 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -10.50 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.40 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -0.39 |